CANCER VACCINES: PIONEERING APPROACHES IN IMMUNOTHERAPY

Q: How many days will it take for my paper to be published?

The review time for papers is not fixed. However, if the paper is accepted and the author completes the processing charges formalities, the paper will be published within a few working days.

Q: I would like to receive a hard copy of the journal materials. Are there any additional charges?

You can log in to the author portal and pay 500 INR to receive the hard copy materials.

MR. ROHIT SHIVCHARAN PATIL; Miss. Swati Samadhan Patil; Miss. Neetu Vicky Patil; Miss. Kamini Eknath Saindane

CANCER VACCINES: PIONEERING APPROACHES IN IMMUNOTHERAPY

Authors: MR. ROHIT SHIVCHARAN PATIL, Miss. Swati Samadhan Patil, Miss. Neetu Vicky Patil, Miss. Kamini Eknath Saindane

Unique Paper ID: 166556
Volume: 11
Issue: 2
PageNo: 1240-1244

Keywords: Dendritic Cells Immunological Surveillance HPV Vaccines Memory T Cells

Abstract:
Cancer remains one of the leading causes of morbidity and mortality worldwide, with millions of new cases diagnosed each year. Despite significant advancements in conventional treatments such as surgery, chemotherapy, and radiation therapy, these modalities often come with severe side effects and are not universally effective. This has led to an increasing interest in harnessing the body's immune system to fight cancer, a strategy known as immunotherapy. Among the various forms of immunotherapy, cancer vaccines have emerged as a promising approach. Unlike traditional vaccines that are designed to prevent infectious diseases, cancer vaccines are developed to either prevent cancer in highrisk individuals or treat existing malignancies. These vaccines work by stimulating the immune system to recognize and attack cancer cells, which often evade immune detection by masquerading as normal cells. This review aims to provide a comprehensive overview of cancer vaccines, discussing their types, mechanisms of action, current state of clinical development, recent advances, and future directions. By exploring the evolving landscape of cancer vaccines, we seek to highlight their potential to transform cancer treatment and improve patient outcomes.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 11
Issue: 2
PageNo: 1240-1244

CANCER VACCINES: PIONEERING APPROACHES IN IMMUNOTHERAPY

Available:https://ijirt.org/article?manuscript=166556

21 Jul, 2025

CHEMOKINE RECEPTORS (E.G., CCR5, CXCR4) AS THERAPEUTIC TARGETS IN CANCER METASTASIS AND HIV

30 May, 2025

Artificial Intelligence in General Anaesthesia: Applications in Monitoring, Prediction, and Automation

11 Mar, 2025

Endocrine Pharmacology: Advances in Diabetes and Obesity Treatment

11 Mar, 2025

Drug-Induced Hypersensitivity: Mechanisms, Risk Factors, and Management Strategies

04 Jan, 2025

IMPACT OF ANTIBIOTICS ON HUMAN GUT MICROBIOTA: SHORT- AND LONG-TERM EFFECTS

03 Jan, 2025

Ethnopharmacology of Hepatoprotection: A Comprehensive Review of Medicinal Plants with Emphasis on Coptis teeta Wall

02 Jan, 2025

FORMULATION AND EVALUATION OF HERBAL-INFUSED LIP BALM: A STUDY ON STABILITY, EFFICACY, AND CONSUMER ACCEPTABILITY

27 Nov, 2024

NEXT-GENERATION HUMAN CELL CULTURE MODELS: REVOLUTIONIZING DRUG DISCOVERY AND SAFETY ASSESSMENT

20 Nov, 2024

ANTI-AGING FORMULATION USING HERBAL CREAMS

21 Oct, 2024

PHARMACOVIGILANCE IN THE ERA OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now